According to Aurinia Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 5.06153.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 3.39 | -0.61% |
2023-12-31 | 3.42 | 125.59% |
2022-12-31 | 1.51 | -75.54% |
2021-12-31 | 6.19 | 44.81% |
2020-12-31 | 4.27 | -43.27% |
2019-12-31 | 7.54 | 45.62% |
2018-12-31 | 5.17 | 124.19% |
2017-12-31 | 2.31 | -0.49% |
2016-12-31 | 2.32 | -42.81% |
2015-12-31 | 4.06 | 20.78% |
2014-12-31 | 3.36 | -1.87% |
2013-12-31 | 3.42 | -167.97% |
2012-12-31 | -5.03 | -257.89% |
2011-12-31 | 3.19 | -50.1% |
2010-12-31 | 6.39 | 48.51% |
2009-12-31 | 4.30 | |
2008-12-31 | N/A | |
2007-12-31 | N/A | |
2006-12-31 | N/A | |
2005-12-31 | N/A | |
2004-12-31 | N/A | |
2003-12-31 | N/A | |
2002-12-31 | N/A |